Literature DB >> 24928373

Factors associated with in utero demise of fetuses that have underlying cardiac pathologies.

Christine E MacColl1, Cedric Manlhiot, Christiana Page, Brian W McCrindle, Steven E S Miner, Edgar T Jaeggi, Lynne E Nield.   

Abstract

Factors associated with in utero fetal demise (IUFD) of fetuses that have underlying cardiac pathologies are largely unknown. This case-control study aimed to define the prevalence of IUFD in fetuses with a diagnosis of cardiac pathologies and to identify prenatal predictors of IUFD. Between January 2004 and December 2010, 74 IUFD cases [4.6 %; 95 % confidence interval (CI) 3.7-5.8 %] were identified from 1,584 cases with a diagnosis of structural or functional cardiac lesions in the Hospital for Sick Children database. The cases were divided into right-sided (N = 28), left-sided (N = 23), great artery (N = 8), and miscellaneous (N = 15) groups. The control subjects (1:1 ratio) were fetuses that had cardiac pathology diagnosed within 48 h of the IUFD case. Multivariable regression models were used to determine echocardiographic predictors of IUFD. The prevalence of IUFD was greatest in hypertrophic cardiomyopathy (8/16, 50 %) and Ebstein's anomaly/tricuspid dysplasia (4/15, 27 %) and lowest in transposition of the great arteries (2/85, 1 %). The findings showed IUFD to be associated with hydrops in 17 (23 %) of the 74 cases and arrhythmia in 11 (15 %) of the 74 cases. The factors identified by univariable logistic regression analyses were right ventricular dysfunction [odds ratio (OR) 2.7; p = 0.001], left ventricular dysfunction (OR 1.8; p = 0.007), umbilical vein pulsations (OR 10.9; p = 0.002), and abnormal ductus venosus flow (OR 3.3; p = 0.01). The factors associated with IUFD in multivariable logistic regression models were cardiomegaly (OR 5.6; p = 0.01), hydrops (OR 29.5; p = 0.001), pericardial effusion (OR 4.1; p = 0.06), and extracardiac abnormalities (OR 7.2; p < 0.001). The prevalence of IUFD is greatest in conditions affecting the ventricular myocardium. The onset of IUFD appears to be related initially to right ventricular dysfunction. Closer surveillance is recommended for lesions at risk of IUFD.

Entities:  

Mesh:

Year:  2014        PMID: 24928373     DOI: 10.1007/s00246-014-0943-1

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  43 in total

Review 1.  Developmental patterning of the myocardium.

Authors:  D Sedmera; T Pexieder; M Vuillemin; R P Thompson; R H Anderson
Journal:  Anat Rec       Date:  2000-04-01

2.  Influence of RV restrictive physiology on LV diastolic function in children after tetralogy of Fallot repair.

Authors:  Nauman Ahmad; Paul F Kantor; Lars Grosse-Wortmann; Neil Seller; Edgar T Jaeggi; Mark K Friedberg; Luc Mertens
Journal:  J Am Soc Echocardiogr       Date:  2012-06-21       Impact factor: 5.251

3.  Development of Z-scores for fetal cardiac dimensions from echocardiography.

Authors:  C Schneider; B W McCrindle; J S Carvalho; L K Hornberger; K P McCarthy; P E F Daubeney
Journal:  Ultrasound Obstet Gynecol       Date:  2005-11       Impact factor: 7.299

4.  Myocardial tissue Doppler and long axis function in the fetal heart.

Authors:  Helena M Gardiner; Lucia Pasquini; Joanne Wolfenden; Anna Barlow; Wei Li; Elena Kulinskaya; Michael Henein
Journal:  Int J Cardiol       Date:  2005-12-19       Impact factor: 4.164

Review 5.  Distribution and regulation of blood flow in the fetal and neonatal lamb.

Authors:  A M Rudolph
Journal:  Circ Res       Date:  1985-12       Impact factor: 17.367

6.  Mild tricuspid regurgitation: a benign fetal finding at various stages of pregnancy.

Authors:  B Messing; S Porat; T Imbar; D V Valsky; E Y Anteby; S Yagel
Journal:  Ultrasound Obstet Gynecol       Date:  2005-11       Impact factor: 7.299

7.  Fetal aortic valve stenosis and the evolution of hypoplastic left heart syndrome: patient selection for fetal intervention.

Authors:  Kaarin Mäkikallio; Doff B McElhinney; Jami C Levine; Gerald R Marx; Steven D Colan; Audrey C Marshall; James E Lock; Edward N Marcus; Wayne Tworetzky
Journal:  Circulation       Date:  2006-03-13       Impact factor: 29.690

8.  Fetal cardiomyopathies: pathogenic mechanisms, hemodynamic findings, and clinical outcome.

Authors:  Simone R F F Pedra; Jeffrey F Smallhorn; Greg Ryan; David Chitayat; Glenn P Taylor; Rubina Khan; Mohamed Abdolell; Lisa K Hornberger
Journal:  Circulation       Date:  2002-07-30       Impact factor: 29.690

9.  Human fetal cardiovascular profile score and neonatal outcome in intrauterine growth restriction.

Authors:  K Mäkikallio; J Räsänen; T Mäkikallio; O Vuolteenaho; J C Huhta
Journal:  Ultrasound Obstet Gynecol       Date:  2008-01       Impact factor: 7.299

10.  The twin-twin transfusion syndrome: spectrum of cardiovascular abnormality and development of a cardiovascular score to assess severity of disease.

Authors:  Jack Rychik; Zhiyun Tian; Michael Bebbington; Feng Xu; Margaret McCann; Stephanie Mann; R Douglas Wilson; Mark P Johnson
Journal:  Am J Obstet Gynecol       Date:  2007-10       Impact factor: 8.661

View more
  3 in total

1.  Recurrence pattern of non-syndromic familial congenital heart diseases among a large cohort of families from Egypt.

Authors:  Shaimaa Rakha; Rehab Mohy-Eldeen; Mohammad Al-Haggar; Mohammed Attia El-Bayoumi
Journal:  BMC Pediatr       Date:  2022-10-19       Impact factor: 2.567

2.  Differences in Contractile Function of Myofibrils within Human Embryonic Stem Cell-Derived Cardiomyocytes vs. Adult Ventricular Myofibrils Are Related to Distinct Sarcomeric Protein Isoforms.

Authors:  Bogdan Iorga; Kristin Schwanke; Natalie Weber; Meike Wendland; Stephan Greten; Birgit Piep; Cristobal G Dos Remedios; Ulrich Martin; Robert Zweigerdt; Theresia Kraft; Bernhard Brenner
Journal:  Front Physiol       Date:  2018-01-19       Impact factor: 4.566

3.  Mortality for Critical Congenital Heart Diseases and Associated Risk Factors in Newborns. A Cohort Study.

Authors:  Selma Alves Valente do Amaral Lopes; Isabel Cristina Britto Guimarães; Sofia Fontes de Oliva Costa; Angelina Xavier Acosta; Kyoko Abe Sandes; Carlos Maurício Cardeal Mendes
Journal:  Arq Bras Cardiol       Date:  2018-09-21       Impact factor: 2.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.